Dale Wahlstrom Retires From LifeScience Alley

Wed, 03/19/2014 - 4:12pm
Associated Press

MINNEAPOLIS - LifeScience Alley announced today that Dale Wahlstrom has elected to retire from LifeScience Alley and The BioBusiness Alliance of Minnesota, effective August 15, 2014, but will step down as president and CEO on May 1, providing support to the leadership transition and completing several strategic initiatives currently underway. The LifeScience Alley Board of Directors has selected Executive Vice President and Chief Operating Officer Shaye Mandle to lead the organization as president and CEO effective May 1.

“LifeScience Alley is grateful to Dale Wahlstrom for his strong and insightful leadership over the past 10 years,” stated Steve Snyder, LifeScience Alley board chair and president and chief operating officer of Neogen Corporation. “His focus on retaining and growing Minnesota’s leadership in the life sciences has brought a new level of recognition and distinction to LifeScience Alley and our region. As the organization celebrates its 30 year anniversary, we are excited about our future and look to Shaye to guide LifeScience Alley through the next phase of its growth as a globally respected trade association.”

Wahlstrom and Mandle have worked closely on key LifeScience Alley (LSA) initiatives, including the expansion of LSA’s public policy efforts and the creation of the Medical Device Innovation Consortium (MDIC), a public-private partnership between the medical device industry and the FDA’s Center for Devices and Radiological Health. “Dale has been a tremendous mentor to me,” Mandle stated. “I am excited to continue LSA’s legacy of representing this community and to push us further as one of the world’s great associations.”

“It has been an honor for me to serve our life science communities over the past 10 years,” said Wahlstrom. “Shaye will be an excellent leader for our organization and I look forward to working with him in our new capacities.”

“With Shaye’s unique background of public and private business leadership and policy work, and his current knowledge of how LifeScience Alley and its subsidiaries serve the industry and the region, we are pleased to have Shaye assume the role of president and CEO,” said Bill McCormack, board chair of The BioBusiness Alliance of Minnesota. “We are grateful for what has been accomplished under Dale’s leadership and eager to work in partnership with Shaye to move our organizations into the future."


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.